2023 annual financial data
Sarepta Therapeutics 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -40.29%.
Operating income was -267,824,000 USD and net income was -535,977,000 USD.
Operating cash flow was -500,993,000 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,243,336,000 USD
- Operating income
- -267,824,000 USD
- Net income
- -535,977,000 USD
- Operating cash flow
- -500,993,000 USD